Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 98 of 1,261
  1. US 12072338

    Pharmaceutical peptides for the treatment of inflammatory diseases

    PROTAGONISTS LTD. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  2. US 12071516

    Polymeric stabilizing formulations

    Nano Precision Medical, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  3. US 12071477

    Anti-folate receptor alpha antibody conjugated with hemiasterlins

    Sutro Biopharma, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  4. US 12071442

    Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists

    Nimbus Saturn, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  5. US 12071438

    Crystal forms of an ALK2 inhibitor

    Keros Therapeutics, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  6. US 12071436

    Anti-parasitic compounds and uses thereof

    The Regents of the University of California · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  7. US 12070509

    Nucleic acids and methods of treatment for cystic fibrosis

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  8. US 12071468

    Purification of Factor VIII subspecies

    Takeda Pharmaceutical Company Limited · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  9. US 12071636

    Pasteurella multocida strains and vaccines having hyaC and nanP deletions

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  10. US 12070506

    Steroids and antibody-conjugates thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  11. US 12071413

    Azole derivatives as apelin receptor agonist

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  12. US 12070510

    Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid

    REGENXBIO INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  13. US 12070472

    Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds

    The Board of Regents of the University of Texas System · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  14. US 12070460

    Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  15. US 12071434

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  16. US 12070594

    Biomedical electrode with anti-microbial properties

    COMPASS HEALTH BRANDS CORP. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  17. US 12071414

    Apelin receptor agonists and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  18. US 12070443

    Methods of treating and preventing breast cancer with S-equol

    The Board of Regents of the University of Texas System · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  19. US 12070502

    Process for reducing subvisible particles in a pharmaceutical formulation

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  20. US 12070500

    Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis

    VACCINEX, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  21. US 12070495

    HIV RNA vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  22. US 12071411

    Inhibitors of HIF-2α and methods of use thereof

    Arcus Biosciences, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  23. US 12071391

    Methods for making and using endoxifen

    ATOSSA THERAPEUTICS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  24. US 12064399

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.